American Medline's shareholders, including the Blackstone and Carlyle Group funds, raised $2.1 billion in the sale of shares, reports Bloomberg. Investors sold 60 million securities at a price of $35.50 per share. The company itself will not receive funds from the deal, but will buy back shares worth up to $200 million. Madeline fell 3.8% on Tuesday.